Navigation Links
Compound may provide drug therapy approach for Huntington's disease

DALLAS June 23, 2011 UT Southwestern Medical Center researchers have identified compounds that appear to inhibit a signaling pathway in Huntington's disease, a finding that may eventually lead to a potential drug therapy to help slow the progression of degenerative nerve disorders.

"Our studies have uncovered a new therapeutic target for Huntington's disease treatment and possibly for other neurodegenerative diseases," said Dr. Ilya Bezprozvanny, professor of physiology and senior author of the study, published in today's issue of Chemistry and Biology. "In addition, we now have this new series of compounds that gives us a tool to study the pathogenesis of Huntington's disease."

Huntington's disease is a fatal genetic disorder in which certain brain cells waste away. More than 250,000 people in the U.S. have the disorder or are at risk for it. The most common form is adult-onset, with symptoms usually developing in patients in their mid-30s and 40s.

The disease results in uncontrolled movements, psychiatric disturbance, gradual dementia and eventually death. There is no therapy available currently to slow the progression of the disease.

Scientists at UT Southwestern found that quinazoline-derived compounds effectively block what is known as the store-operated calcium entry signaling pathway, which was never before implicated in Huntington nerve cells but that might be a therapeutic target in the disease.

Dr. Bezprozvanny's laboratory research has contributed to growing scientific evidence that suggests abnormalities in neuronal calcium signaling play an important role in the development of Huntington's disease. UT Southwestern researchers demonstrated in the current study that the quinoline compounds supplied by EnVivo protected brain cells.

"If this holds, this compound can be considered to have potential therapeutic application for Huntington's," he said. "As we ultimately seek a cure, we a

Contact: Robin Russell
UT Southwestern Medical Center

Page: 1 2

Related biology news :

1. Toxic compounds in groundwater
2. TGen study identifies compounds that could slow down Alzheimers disease
3. Mushroom compound suppresses prostate tumors
4. Scientists find new class of compounds with great potential for research and drug development
5. URI scientist discovers 54 beneficial compounds in pure maple syrup
6. New data published in Nature Genetics demonstrate that tiny LNA-based compounds developed by Santaris Pharma A/S inhibit entire disease-associated microRNA families
7. Rockefeller Scientists discover new compound that rids cells of Alzheimer protein debris
8. Compound useful for studying birth defects may also have anti-tumor properties
9. Chemical compounds in trees can fight deadly staph infections in humans
10. Antifungal compound found on tropical seaweed has promising antimalarial properties
11. UT researchers link algae to harmful estrogen-like compound in water
Post Your Comments:
(Date:9/30/2015)... Sept. 30, 2015  The global glucose monitoring device and ... So says a new report on the industry from Kalorama ... dominate the market, followed by continuous glucose monitoring and sensor ... the market for these products in its latest report, ... , ...
(Date:9/28/2015)... NEW YORK , Sept. 28, 2015 /PRNewswire/ ... rate, respiration rate and body temperature, is an ... signs can be indicators of deterioration in a ... the hospital, vital signs are typically taken during ... eight hours. If a patient deteriorates between these ...
(Date:9/26/2015)... , Sept. 26th, 2015  Results of a ... be unveiled today at the Stanford Medicine X ... Using iPad Dashboards, Connected Health Devices and Pharmacogenomics", ... Pharmacy 3.0, will explain how senior patients equipped ... to their pharmacist via the TactioRPM remote patient ...
Breaking Biology News(10 mins):
... by Stephen Dalton, professor and Georgia Research Alliance Eminent ... has been awarded $9.2 million as part of a ... General Medical Sciences, part of the National Institutes of ... biochemistry and molecular biology, will address the molecular underpinnings ...
... Models & Mechanisms ( DMM ) is the first ... model organisms to advance human health. Published by the ... biomedical research journal which officially launched its inaugural issue both ... DMM focuses on human disease and the research ...
... they have also calculated that the bite force of ... Carcharodon megalodon (also known as Big Tooth) ... the most formidable carnivore ever to have existed. ... Newcastle University, NSW Department of Primary Industries Fisheries (Australia) ...
Cached Biology News:
(Date:10/9/2015)...  Pulmatrix, Inc., (NASDAQ: PULM ) will be webcasting ... th Annual BIO Investor Forum on Tuesday, ... --> th Annual BIO Investor Forum ... pm EDT). --> Pulmatrix will be presenting ... on Thursday, October 15, 2015 at 8:30 am EDT. Additionally, ...
(Date:10/8/2015)... SAN DIEGO , Oct. 8, 2015 /PRNewswire/ ... oncology company developing new treatments for cancer and ... Chief Executive Officer, will be presenting at the ... Las Vegas :Event:Aegis Capital Corporation 2015 ... PDTLocation:Brahms 2 room, The Encore @ The Wynn ...
(Date:10/8/2015)... 2015 .   ... Goldman Small Cap Research, a stock market ... microcap sectors, announced today that it has published ... Inc. (OTCQB - PMCB), a publicly traded, clinical ... treatments for cancer and diabetes. To view the ...
(Date:10/8/2015)... 2015 /PRNewswire/ - RepliCel Life Sciences Inc. (OTCQB: REPCF) (TSX.V: ... the development of autologous cell therapies, today announced its schedule ... place in the month of October: Stem ... RepliCel will be presenting at the annual Partnering Forum, ... to be held October 7-9 in La ...
Breaking Biology Technology:
... processes with enterprise-centric Internet tools is hardly new, but one ... that reluctant business leaders need an education in Web 2.0. ... to a lack of information. Building on Internet expert Tim ... bloggers like Dion Hinchcliffe , Rod Boothby , ...
... pressure from expiring patents, generic drugs, and increasing ... pharmaceutical companies are increasingly turning to innovative biotechnology ... produce new business opportunities. , ,At a recent ... Device Association , pharmaceutical company representatives from ...
... Wis. - People usually enter contests to win prizes, ... no exception to the rule. About $450,000 in cash and ... years. , ,But the real prize in this statewide contest ... a splash. , ,Since its birth in 2004, the Governor's ...
Cached Biology Technology: